(SMR) Nuscale Power - Overview
Stock: Small Modular Reactor, NuScale Power Module, Water Reactor, 77 MWe
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 131% |
| Relative Tail Risk | -9.86% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.23 |
| Alpha | -59.63 |
| Character TTM | |
|---|---|
| Beta | 2.333 |
| Beta Downside | 2.018 |
| Drawdowns 3y | |
|---|---|
| Max DD | 82.06% |
| CAGR/Max DD | 0.22 |
Description: SMR Nuscale Power January 08, 2026
NuScale Power Corp. (NYSE: SMR) develops small modular reactor (SMR) technology, centered on its 77 MW(e) NuScale Power Module (NPM) water-cooled reactor. Founded in 2007 and based in Corvallis, Oregon, the firm targets utility-scale clean-energy projects that can be factory-built and deployed faster than traditional large reactors.
Key industry metrics that shape NuScale’s outlook include: (1) the U.S. Department of Energy’s $2.5 billion loan-guarantee program for SMRs, which de-risks capital costs; (2) an emerging market demand for low-carbon baseload power, projected to grow at ~3 % CAGR through 2035 as states tighten renewable-energy mandates; and (3) NuScale’s recent $200 million contract pipeline for projects in Idaho, Utah, and Canada, indicating traction despite the lengthy regulatory approval timeline (typically 5-7 years from design certification to commercial operation). The broader nuclear sector is also benefitting from a declining cost per kilowatt for SMRs-estimated at $5,500/kW versus $8,000/kW for conventional reactors-driven by modular construction and supply-chain efficiencies.
For a deeper dive into NuScale’s financials, risk profile, and valuation multiples, you may find ValueRay’s analyst toolkit useful for independent research.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income: -379.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.32 > 0.02 and ΔFCF/TA 29.41 > 1.0 |
| NWC/Revenue: 429.1% < 20% (prev 1355 %; Δ -925.6% < -1%) |
| CFO/TA -0.32 > 3% & CFO -282.3m > Net Income -379.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (147.7m) vs 12m ago 55.14% < -2% |
| Gross Margin: 66.76% > 18% (prev 0.23%; Δ 6654 % > 0.5%) |
| Asset Turnover: 11.24% > 50% (prev 2.91%; Δ 8.33% > 0%) |
| Interest Coverage Ratio: -3.90 > 6 (EBITDA TTM -618.3m / Interest Expense TTM 159.0m) |
Altman Z'' -9.41
| A: 0.31 (Total Current Assets 719.8m - Total Current Liabilities 445.6m) / Total Assets 883.1m |
| B: -0.77 (Retained Earnings -682.0m / Total Assets 883.1m) |
| C: -1.09 (EBIT TTM -619.7m / Avg Total Assets 568.2m) |
| D: -1.52 (Book Value of Equity -682.0m / Total Liabilities 448.3m) |
| Altman-Z'' Score: -9.41 = D |
Beneish M 0.91
| DSRI: 0.22 (Receivables 15.2m/7.91m, Revenue 63.9m/7.38m) |
| GMI: 0.34 (GM 66.76% / 22.50%) |
| AQI: 0.66 (AQ_t 0.18 / AQ_t-1 0.28) |
| SGI: 8.66 (Revenue 63.9m / 7.38m) |
| TATA: -0.11 (NI -379.9m - CFO -282.3m) / TA 883.1m) |
| Beneish M-Score: 0.91 (Cap -4..+1) = D |
What is the price of SMR shares?
Over the past week, the price has changed by +0.29%, over one month by -10.42%, over three months by -46.00% and over the past year by -24.60%.
Is SMR a buy, sell or hold?
- StrongBuy: 6
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the SMR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 34.2 | 95% |
| Analysts Target Price | 34.2 | 95% |
| ValueRay Target Price | 16.5 | -5.9% |
SMR Fundamental Data Overview February 03, 2026
P/B = 6.4575
Revenue TTM = 63.9m USD
EBIT TTM = -619.7m USD
EBITDA TTM = -618.3m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -407.6m USD (from netDebt column, last quarter)
Enterprise Value = 4.54b USD (4.94b + (null Debt) - CCE 407.6m)
Interest Coverage Ratio = -3.90 (Ebit TTM -619.7m / Interest Expense TTM 159.0m)
EV/FCF = -16.06x (Enterprise Value 4.54b / FCF TTM -282.5m)
FCF Yield = -6.23% (FCF TTM -282.5m / Enterprise Value 4.54b)
FCF Margin = -442.1% (FCF TTM -282.5m / Revenue TTM 63.9m)
Net Margin = -594.6% (Net Income TTM -379.9m / Revenue TTM 63.9m)
Gross Margin = 66.76% ((Revenue TTM 63.9m - Cost of Revenue TTM 21.2m) / Revenue TTM)
Gross Margin QoQ = 32.87% (prev 22.11%)
Tobins Q-Ratio = 5.14 (Enterprise Value 4.54b / Total Assets 883.1m)
Interest Expense / Debt = unknown (Interest Expense 2.11m / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = -489.5m (EBIT -619.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.62 (Total Current Assets 719.8m / Total Current Liabilities 445.6m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = 0.66 (negative EBITDA) (Net Debt -407.6m / EBITDA -618.3m)
Debt / FCF = 1.44 (negative FCF - burning cash) (Net Debt -407.6m / FCF TTM -282.5m)
Total Stockholder Equity = 711.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -66.87% (Net Income -379.9m / Total Assets 883.1m)
RoE = -53.43% (Net Income TTM -379.9m / Total Stockholder Equity 711.1m)
RoCE = -141.6% (out of range, set to none) (EBIT -619.7m / Capital Employed (Total Assets 883.1m - Current Liab 445.6m))
RoIC = -68.85% (negative operating profit) (NOPAT -489.5m / Invested Capital 711.1m)
WACC = 14.51% (E(4.94b)/V(4.94b) * Re(14.51%) + (debt-free company))
Discount Rate = 14.51% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 38.59%
Fair Price DCF = unknown (Cash Flow -282.5m)
EPS Correlation: -37.05 | EPS CAGR: 1.94% | SUE: 0.26 | # QB: 0
Revenue Correlation: 34.72 | Revenue CAGR: 56.71% | SUE: -0.21 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.13 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=5
EPS next Year (2026-12-31): EPS=-0.57 | Chg30d=+0.017 | Revisions Net=+0 | Growth EPS=+74.1% | Growth Revenue=+210.7%